search
Back to results

Comparison of Exsufflation Versus Drainage in Primary Spontaneous Pneumothorax (EXPRED)

Primary Purpose

Pneumothorax

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
exsufflation
thoracic tube drainage
Sponsored by
Centre Hospitalier Universitaire de Besancon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pneumothorax focused on measuring spontaneous, primary, first episode

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients aged more than 18 years and less than 50 years
  • first episode of pneumothorax
  • primary pneumothorax (absence of known pulmonary disease)
  • large size of pneumothorax : presence of a visible rim of air between the lund margin and the chest wall, from the apex to pulmonary base

Exclusion Criteria:

  • impossibility to obtain patient consent for psychiatric disease
  • patients under justice control
  • âgé less than 18 years, or more than 50 years
  • impossibility of medical follow de for geographic, social or psychic reasons
  • pregnant women
  • pneumothorax with acute respiratory insufficiency or bad tolerated
  • recidive of pneumothorax
  • traumatic pneumothorax
  • pneumothorax with pleural effusion
  • bilatéral pneumothorax
  • pneumothorax with pulmonary disease

Sites / Locations

  • Centre Hospitalier Intercommunal de la Haute Saône
  • CHU Angers
  • Hôpital Henri Mondor
  • Centre Hospitalier
  • CHU Besancon
  • CH Bethune
  • CH Boulogne sur Mer
  • CHU Clermont Ferrand
  • CHU Dijon
  • CHU Grenoble
  • Clinique de HENIN BEAUMONT
  • CH Lomme
  • CHU Marseille
  • Chi Le Raincy/Montfermeil
  • CH Mulhouse
  • CHU Nimes
  • CH Perpignan
  • CHU Poitiers
  • CHU Reims
  • CHR Roubaix
  • CH Rouen
  • CHU Saint Etienne
  • CHU Toulouse
  • CHU Tours

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

tube thoracic drainage

exsufflation

Arm Description

drainage performed with tube drainage CH 16 or ch 20

exsufflation with a specific thoracentesis system

Outcomes

Primary Outcome Measures

size of residual pneumothorax measured on chest radiography

Secondary Outcome Measures

size of residual pneumothorax at one week
recidive of pneumothorax at one year

Full Information

First Posted
September 9, 2009
Last Updated
February 10, 2020
Sponsor
Centre Hospitalier Universitaire de Besancon
Collaborators
Centre Hospitalier Universitaire Dijon, Belfort Hospital, Central Hospital, Nancy, France, Norman Bethune Medical Hospital, St Philibert Hospital, Lomme, Hospital of Montfermeil, University Hospital, Brest, University Hospital, Clermont-Ferrand, Nantes University Hospital, Association Hospitalière Nord Artois Cliniques, Poitiers University Hospital, University Hospital, Tours, CHU de Reims, Hospital of Perpignan, Hospices Civils de Lyon, Centre Hospitalier Universitaire de Saint Etienne, Hospital of Roubaix, Hospital of Boulogne/mer, Assistance Publique Hopitaux De Marseille, University Hospital, Rouen, University Hospital, Angers, Centre Hospitalier le Mans, Centre Hospitalier Universitaire de Nīmes, University Hospital, Grenoble, Hospital of Mulhouse, Hospital of Valence
search

1. Study Identification

Unique Protocol Identification Number
NCT01008228
Brief Title
Comparison of Exsufflation Versus Drainage in Primary Spontaneous Pneumothorax
Acronym
EXPRED
Official Title
Comparison of Efficacity of Simple Aspiration Versus Standard Drainage in the Management of Large Size Primary Spontaneous Pneumothorax
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
June 2009 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
December 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centre Hospitalier Universitaire de Besancon
Collaborators
Centre Hospitalier Universitaire Dijon, Belfort Hospital, Central Hospital, Nancy, France, Norman Bethune Medical Hospital, St Philibert Hospital, Lomme, Hospital of Montfermeil, University Hospital, Brest, University Hospital, Clermont-Ferrand, Nantes University Hospital, Association Hospitalière Nord Artois Cliniques, Poitiers University Hospital, University Hospital, Tours, CHU de Reims, Hospital of Perpignan, Hospices Civils de Lyon, Centre Hospitalier Universitaire de Saint Etienne, Hospital of Roubaix, Hospital of Boulogne/mer, Assistance Publique Hopitaux De Marseille, University Hospital, Rouen, University Hospital, Angers, Centre Hospitalier le Mans, Centre Hospitalier Universitaire de Nīmes, University Hospital, Grenoble, Hospital of Mulhouse, Hospital of Valence

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Management of primary spontaneous pneumothorax (PSP) remains unclear. Primary therapeutic goals for PSP include removal of air from the pleural space an prevention of recurrences. The absence of generally accepted and methodologically sound recommendations may account for the extensive variation in practice for air evacuation techniques. Air evacuation may be achieved by simple aspiration (exsufflation) or conventional chest tube drainage. Chest tube thoracotomy remains the most popular technique.Aspiration is a more simple technique, that allows possibility of ambulatory management. The purpose of the present study is to compare simple aspiration performed with a specific thoracentesis device, versus conventional chest tube drainage. Comparison will be performed on immediate efficacity of resolution of the pneumothorax.The hypothesis is that simple aspiration performed with a specific device is not inferior to chest tube drainage for management of a first episode of large size primary spontaneous pneumothorax. A second goal is to measure the efficacy at one week, and the recidive at one year. The trial is randomized, controlled and will include 200 patients for each group. The patients will be enrolled in 29 hospitals in France. Emergency department, thoracic surgery and pulmonary departments of each hospital were primarily contacted for agreement to participate to the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pneumothorax
Keywords
spontaneous, primary, first episode

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
402 (Actual)

8. Arms, Groups, and Interventions

Arm Title
tube thoracic drainage
Arm Type
Active Comparator
Arm Description
drainage performed with tube drainage CH 16 or ch 20
Arm Title
exsufflation
Arm Type
Experimental
Arm Description
exsufflation with a specific thoracentesis system
Intervention Type
Procedure
Intervention Name(s)
exsufflation
Other Intervention Name(s)
Turkel Kit
Intervention Description
exsufflation will be performed with a specific thoracentesis system after introducing the device into chest pneumothorax, aspiration will be performed during 30 minutes
Intervention Type
Procedure
Intervention Name(s)
thoracic tube drainage
Other Intervention Name(s)
Monod Trocar, Chest Tube
Intervention Description
thoracic tube drainage will be performed with a tube Ch 16 or ch 20
Primary Outcome Measure Information:
Title
size of residual pneumothorax measured on chest radiography
Time Frame
one day
Secondary Outcome Measure Information:
Title
size of residual pneumothorax at one week
Time Frame
one week
Title
recidive of pneumothorax at one year
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients aged more than 18 years and less than 50 years first episode of pneumothorax primary pneumothorax (absence of known pulmonary disease) large size of pneumothorax : presence of a visible rim of air between the lund margin and the chest wall, from the apex to pulmonary base Exclusion Criteria: impossibility to obtain patient consent for psychiatric disease patients under justice control âgé less than 18 years, or more than 50 years impossibility of medical follow de for geographic, social or psychic reasons pregnant women pneumothorax with acute respiratory insufficiency or bad tolerated recidive of pneumothorax traumatic pneumothorax pneumothorax with pleural effusion bilatéral pneumothorax pneumothorax with pulmonary disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thibaut TJ Desmettre
Organizational Affiliation
Hospital University of Besancon
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thibaut DESMETTRE, MD
Organizational Affiliation
CHU Besançon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Intercommunal de la Haute Saône
City
Vesoul
State/Province
Franche Comté
ZIP/Postal Code
70000
Country
France
Facility Name
CHU Angers
City
Angers
ZIP/Postal Code
49100
Country
France
Facility Name
Hôpital Henri Mondor
City
Aurillac
ZIP/Postal Code
15000
Country
France
Facility Name
Centre Hospitalier
City
Belfort
ZIP/Postal Code
90016
Country
France
Facility Name
CHU Besancon
City
Besançon
ZIP/Postal Code
25030
Country
France
Facility Name
CH Bethune
City
Bethune
ZIP/Postal Code
62400
Country
France
Facility Name
CH Boulogne sur Mer
City
Boulogne sur Mer
ZIP/Postal Code
62320
Country
France
Facility Name
CHU Clermont Ferrand
City
Clermont Ferrand
ZIP/Postal Code
63003
Country
France
Facility Name
CHU Dijon
City
Dijon
ZIP/Postal Code
21033
Country
France
Facility Name
CHU Grenoble
City
Grenoble
ZIP/Postal Code
38043
Country
France
Facility Name
Clinique de HENIN BEAUMONT
City
Henin Beaumont
ZIP/Postal Code
62110
Country
France
Facility Name
CH Lomme
City
Lomme
ZIP/Postal Code
59160
Country
France
Facility Name
CHU Marseille
City
Marseille
ZIP/Postal Code
13385
Country
France
Facility Name
Chi Le Raincy/Montfermeil
City
Montfermeil
ZIP/Postal Code
93370
Country
France
Facility Name
CH Mulhouse
City
Mulhouse
ZIP/Postal Code
68051
Country
France
Facility Name
CHU Nimes
City
Nimes
ZIP/Postal Code
30029
Country
France
Facility Name
CH Perpignan
City
Perpignan
ZIP/Postal Code
66046
Country
France
Facility Name
CHU Poitiers
City
Poitiers
ZIP/Postal Code
86000
Country
France
Facility Name
CHU Reims
City
Reims
ZIP/Postal Code
54035
Country
France
Facility Name
CHR Roubaix
City
Roubaix
ZIP/Postal Code
59100
Country
France
Facility Name
CH Rouen
City
Rouen
ZIP/Postal Code
76000
Country
France
Facility Name
CHU Saint Etienne
City
Saint Etienne
ZIP/Postal Code
42050
Country
France
Facility Name
CHU Toulouse
City
Toulouse
ZIP/Postal Code
31059
Country
France
Facility Name
CHU Tours
City
Tours
ZIP/Postal Code
37040
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
21277468
Citation
Desmettre T, Meurice JC, Kepka S, Dalphin JC. [Treatment of first spontaneous pneumothorax: drainage or exsufflation?]. Rev Mal Respir. 2011 Jan;28(1):5-8. doi: 10.1016/j.rmr.2010.10.028. Epub 2011 Jan 12. No abstract available. French.
Results Reference
background
PubMed Identifier
21482337
Citation
Desmettre T, Meurice JC, Mauny F, Woronoff MC, Tiffet O, Schmidt J, Ferretti G, Dalphin JC. [Comparison of simple aspiration versus standard drainage in the treatment of large primary spontaneous pneumothorax]. Rev Mal Respir. 2011 Mar;28(3):336-43. doi: 10.1016/j.rmr.2010.10.030. Epub 2011 Mar 10. French.
Results Reference
background
PubMed Identifier
23318185
Citation
Desmettre T, Meurice JC, Tapponnier R, Pretalli JB, Dalphin JC. [The EXPRED study: where are we?]. Rev Mal Respir. 2013 Jan;30(1):18-21. doi: 10.1016/j.rmr.2012.09.019. Epub 2012 Nov 13. No abstract available. French.
Results Reference
background

Learn more about this trial

Comparison of Exsufflation Versus Drainage in Primary Spontaneous Pneumothorax

We'll reach out to this number within 24 hrs